QUALITY BY DESIGN SUPPORTED CONSTRUCTION OF ORAL FAST-DISSOLVING FILMS FOR TELMISARTAN: RECONNOITERING THE QUALITY ATTRIBUTES
DOI:
https://doi.org/10.22159/ijap.2024v16i2.50094Keywords:
Telmisartan, Pharmacokinetic study, Mucoadhesion, Films, Solvent casting, In vitro studies, Ex vivo studiesAbstract
Objective: The angiotensin II receptor antagonist telmisartan (TMS) is often used to treat hypertension. The BCS class II antihypertensive drug TMS has a low solubility, poorly absorbed when taken orally. The goal of this study was to formulate an oral fast-dissolving film (OFDF) of TMS. In recent years, the concept of a rapidly dissolving dosage form as an innovative delivery system has gained popularity. By decreasing dosing frequency, maximize therapeutic effectiveness, bioavailability, and stability. It will also prevent the drugs from being metabolized in the first place. This technique allows for faster drug absorption from the gastrointestinal tract (GIT), which might result in a more rapid onset of action.
Methods: An experimental design known as Box-Behnken was employed to optimize a OFDF. Mango kernel (100-300 mg), maltodextrin (200-350 mg), and propylene glycol (PG) (15-30%) were chosen as independent variables with the highest preference. Included measurements of T5 tensile strength, disintegration time, folding endurance, elongation, and drug release efficiency as dependent variables.
Results: The physical properties of the films were found to be satisfactory, and Fourier transform infrared (FTIR) analysis failed to detect any drug-polymer interaction. F4 was found to have the greatest bioadhesive strength of 49.82 gm and the longest ex-vivo mucoadhesion duration of 189 min. A higher concentration of mango kernel in the formulation resulted in a greater rate of drug release. More than 60% of the drug was discharged within 10 min.
Conclusion: The oral mucosa of a rat was used for ex-vivo for irritation studies. Based on the pharmacokinetic plasma parameters, which is made into quick-dissolving films that are taken by mouth, is much better absorbed than aqueous suspensions. Studies of the enhanced formulation's stability showed that F4 may be stored for up to three months without deterioration.
Downloads
References
Alkahtani ME, Aodah AH, Abu Asab OA, Basit AW, Orlu M, Tawfik EA. Fabrication and characterization of fast-dissolving films containing escitalopram/quetiapine for the treatment of major depressive disorder. Pharmaceutics. 2021;13(6):891. doi: 10.3390/pharmaceutics13060891, PMID 34208460.
Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139(2):94-107. doi: 10.1016/j.jconrel.2009.06.014, PMID 19559740.
Rowe RC, Sheskey P, Quinn M. Handbook of pharmaceutical excipients. Libros Digitales-Pharmaceutical Press; 2009.
Kulkarni AS, Deokule HA, Mane MS, Ghadge DM. Exploration of different polymers for use in the formulation of oral fast dissolving strips. J Curr Pharm Res. 2010;2(1):33-5.
Abruzzo A, Bigucci F, Cerchiara T, Cruciani F, Vitali B, Luppi B. Mucoadhesive chitosan/gelatin films for buccal delivery of propranolol hydrochloride. Carbohydr Polym. 2012;87(1):581-8. doi: 10.1016/j.carbpol.2011.08.024, PMID 34663007.
Aggarwal J, Singh G, Saini S, Rana AC. Fast dissolving films: a novel approach to oral drug delivery. Int Res J Pharm. 2011;2(12):69-71.
Jadhav SD, Kalambe RN, Jadhav CM, Tekade BW, Patil VR. Formulation and evaluation of fast-dissolving oral film of levocetirizine dihydrochloride. Int J Pharm Pharm Sci. 2012;4Suppl 1:337-41.
Shukla D. Mouth dissolving tablets I: an overview of formulation technology. Sci Pharm. 2009;77(2):309-26. doi: 10.3797/scipharm.0811-09-01.
Mashru RC, Sutariya VB, Sankalia MG, Parikh PP. Development and evaluation of fast-dissolving film of salbutamol sulphate. Drug Dev Ind Pharm. 2005;31(1):25-34. doi: 10.1081/ddc-43947, PMID 15704855.
Husain M, Agnihotri VV, Goyal SN, Agrawal YO. Development, optimization and characterization of hydrocolloid-based mouth dissolving film of telmisartan for the treatment of hypertension. Food Hydrocoll Health. 2022;2:100064. doi: 10.1016/j.fhfh.2022.100064.
Gondaliya K, Kapupara PP, Shah KV. Development and validation of RP-HPLC method for simultaneous estimation of clonidine hydrochloride and hydrochlorothiazide in pharmaceutical formulation. Int Boll Drug Res. 2014;4(6):106-15.
Vasseur B, Dufour A, Houdas L, Goodwin H, Harries K, Emul NY. Comparison of the systemic and local pharmacokinetics of clonidine mucoadhesive buccal tablets with reference clonidine oral tablets in healthy volunteers: an open-label randomised cross-over trial. Adv Ther. 2017;34(8):2022-32. doi: 10.1007/s12325-017-0585-9, PMID 28726169.
Gondkar SB, Namrata P, Saudagar RB. Fast dissolving oral films. Asian J Pharm Res. 2016;6(1):56-8.
Cunningham FE, Baughman VL, Peters J, Laurito CE. Comparative pharmacokinetics of oral versus sublingual clonidine. J Clin Anesth. 1994;6(5):430-3. doi: 10.1016/s0952-8180(05)80018-2, PMID 7986518.
Gilkeson GS, Delaney RL. Effectiveness of sublingual clonidine in patients unable to take oral medication. Drug Intell Clin Pharm. 1987;21(3):262-3. doi: 10.1177/106002808702100305, PMID 3569024.
Isaac J, Ganguly S, Ghosh A. Co-milling of telmisartan with poly(vinyl alcohol)–An alkalinizer free green approach to ensure its bioavailability. Eur J Pharm Biopharm. 2016;101:43-52. doi: 10.1016/j.ejpb.2016.01.016, PMID 26829378.
Segura J, Ruilope LM. A review of the benefits of early treatment initiation with single-pill combinations of telmisartan with amlodipine or hydrochlorothiazide. Vasc Health Risk Manag. 2013;9:521-8. doi: 10.2147/VHRM.S48291, PMID 24082785.
Meredith PA. Optimal dosing characteristics of the angiotensin II receptor antagonist telmisartan. Am J Cardiol. 1999;84(2A):7K-12K. doi: 10.1016/s0002-9149(99)00400-2, PMID 10437738.
Sangwai M, Vavia P. Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability. Int J Pharm. 2013;453(2):423-32. doi: 10.1016/j.ijpharm.2012.08.034, PMID 22935741.
Tran PHL, Tran HTT, Lee BJ. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release. J Control Release. 2008;129(1):59-65. doi: 10.1016/j.jconrel.2008.04.001, PMID 18501462.
Borges AF, Silva BM, Silva C, Coelho JF, Simões S. Hydrophobic polymers for orodispersible films: a quality by design approach. Expert Opin Drug Deliv. (2016);13(10):1357-74. doi: 10.1080/17425247.2016.1218458, PMID 27466880.
Silva BMA, Vicente S, Cunha S, Coelho JFJ, Silva C, Reis MS. Retrospective quality by design (rQbD) applied to the optimization of orodispersible films. Int J Pharm. (2017);528(1-2):655-63. doi: 10.1016/j.ijpharm.2017.06.054, PMID 28629981.
Patil AS, Pethe AM. Quality by design (QbD): a new concept for development of quality pharmaceuticals. Int J Pharm Qual Assur. 2013;4(2):13-9.
Dangre PV, Phad RD, Surana SJ, Chalikwar SS. Quality by design (QbD) assisted fabrication of fast dissolving buccal film for clonidine hydrochloride: exploring the quality attributes. Adv Polym Technol. 2019;2019:1-13. doi: 10.1155/2019/3682402.
Chettupalli AK, Rao PA, Kuchukuntla M, Bakshi V. Development and optimization of aripiprazole ODT by using box-behnken design. Res J Pharm Technol. 2020;13(12):6195-201. doi: 10.5958/0974-360X.2020.01080.X.
Cho HJ, Lee DW, Marasini N, Poudel BK, Kim JH, Ramasamy T. Optimization of self-microemulsifying drug delivery system for telmisartan using box–behnken design and desirability function. J Pharm Pharmacol. 2013;65(10):1440-50. doi: 10.1111/jphp.12115, PMID 24028611.
Amarachinta PR, Sharma G, Samed N, Chettupalli AK, Alle M, Kim JC. Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect. J Nanobiotechnology. 2021;19(1):100. doi: 10.1186/s12951-021-00833-4, PMID 33836744.
Chettupalli AK, Ananthula M, Amarachinta PR, Bakshi V, Yata VK. Design, formulation, in vitro and ex-vivo evaluation of atazanavir loaded cubosomal gel. Biointerface res. J Appl Chem. 2021;11:12037-54.
Unnisa A, Chettupalli AK, Al Hagbani T, Khalid M, Jandrajupalli SB, Chandolu S. Development of dapagliflozin solid lipid nanoparticles as a novel carrier for oral delivery: statistical design, optimization, in vitro and in vivo characterization, and evaluation. Pharmaceuticals (Basel). 2022;15(5):568. doi: 10.3390/ph15050568, PMID 35631394.
Chettupalli AK, Rao PA, Kuchukuntla M, Bakshi V. Development and optimization of aripiprazole ODT by using box-behnken design. Res J Pharm Technol. 2020;13(12):6195-201. doi: 10.5958/0974-360X.2020.01080.X.
El-Setouhy DA, Abd El-Malak NSA. Formulation of a novel tianeptine sodium orodispersible film. AAPS PharmSciTech. 2010;11(3):1018-25. doi: 10.1208/s12249-010-9464-2, PMID 20532710.
Garg T, Murthy RSR, Kumar Goyal A, Arora S, Malik B. Development, optimization and evaluation of porous chitosan scaffold formulation of gliclazide for the treatment of type-2 diabetes mellitus. Drug Deliv Lett. 2012;2(4):251-61. doi: 10.2174/2210304x11202040003.
Kaur R, Garg T, Das Gupta U, Gupta P, Rath G, Goyal AK. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Artif Cells Nanomed Biotechnol. 2016;44(1):182-7. doi: 10.3109/21691401.2014.930747, PMID 24992699.
Prasad RR, Kumar JR, Vasudha B, Kumar CA. Formulation development and evaluation of allopurinol solid dispersions by solvent evaporation technique. Int J App Pharm. 2018;10(4):168-71. doi: 10.22159/ijap.2018v10i4.25311.
Cunningham FE, Baughman VL, Peters J, Laurito CE. Comparative pharmacokinetics of oral versus sublingual clonidine. J Clin Anesth. 1994;6(5):430-3. doi: 10.1016/s0952-8180(05)80018-2, PMID 7986518.
Beg S, Al Robaian M, Rahman M, Imam SS, Alruwaili N, Panda SK. editors. Pharmaceutical drug product development and process optimization: effective use of quality by design. CRC Press; 2020.
Yir-Erong B, Bayor MT, Ayensu I, Gbedema SY, Boateng JS. Oral thin films as a remedy for noncompliance in pediatric and geriatric patients. Ther Deliv. 2019;10(7):443-64. doi: 10.4155/tde-2019-0032, PMID 31264527.
Irfan M, Rabel S, Bukhtar Q, Qadir MI, Jabeen F, Khan A. Orally disintegrating films: a modern expansion in drug delivery system. Saudi Pharm J. 2016;24(5):537-46. doi: 10.1016/j.jsps.2015.02.024, PMID 27752225.
Nalluri BN, Sravani B, Anusha VS, Sribramhini R, Maheswari KM. Development and evaluation of mouth dissolving films of sumatriptan succinate for better therapeutic efficacy. J Appl Pharm Sci. 2013;3(8):161-6.
Rani KC, Parfati N, Aryani NLD, Winantari AN, Fitriani EW, Pradana AT. Development, evaluation, and molecular docking of oral dissolving film of atenolol. Pharmaceutics. 2021;13(10):1727. doi: 10.3390/pharmaceutics13101727, PMID 34684021.
Hussain A, Latif S, Abbas N, Irfan M, Arshad MS, Bukhari NI. Hydroxypropyl cellulose-based orally disintegrating films of promethazine HCl for the treatment of motion sickness. Trop J Pharm Res. 2018;17(6):991-6. doi: 10.4314/tjpr.v17i6.2.
Satyanarayana DA, Keshavarao KP. Fast disintegrating films containing anastrozole as a dosage form for dysphagia patients. Arch Pharm Res. 2012;35(12):2171-82. doi: 10.1007/s12272-012-1215-3, PMID 23263812.
Avula PR, Chettupalli AK, Chauhan V, Jadi RK. Design, formulation, in vitro and in vivo pharmacokinetic evaluation of nicardipine-nanostructured lipid carrier for transdermal drug delivery system. Mater Today Proc. 2023.
Unnisa A, Chettupalli AK, Alazragi RS, Alelwani W, Bannunah AM, Barnawi J. Nanostructured lipid carriers to enhance the bioavailability and solubility of ranolazine: statistical optimization and pharmacological evaluations. Pharmaceuticals (Basel). 2023;16(8):1151. doi: 10.3390/ph16081151, PMID 37631066.
Sameina LH, Idamakantia S, Chettupalli AK, Velamala RR, Ezzat MO. Design of mesalamine loaded micro-particles: Preparation, in vitro and in vivo characterization. Mater Today Proc. 2023. doi: 10.1016/j.matpr.2023.07.063.
Dandamudi SP, Chettupalli AK, Dargakrishna SP, Nerella M, Amara RR, Yata VK. Response surface method for the simultaneous estimation of atorvastatin and olmesartan. Trends Sci. 2022;19(18):5799. doi: 10.48048/tis.2022.5799.
Samprasit W, Akkaramongkolporn P, Kaomongkolgit R, Opanasopit P. Cyclodextrin-based oral dissolving films formulation of taste-masked meloxicam. Pharm Dev Technol. 2018;23(5):530-9. doi: 10.1080/10837450.2017.1401636, PMID 29103353.
Maher EM, Ali AMA, Salem HF, Abdelrahman AA. In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids. Drug Deliv. 2016;23(8):3088-100. doi: 10.3109/10717544.2016.1153746, PMID 26960680.
Shen BD, Shen CY, Yuan XD, Bai JX, Lv QY, Xu H. Development and characterization of an orodispersible film containing drug nanoparticles. Eur J Pharm Biopharm. 2013;85(3 Pt B):1348-56. doi: 10.1016/j.ejpb.2013.09.019, PMID 24103635.
Mashru RC, Sutariya VB, Sankalia MG, Parikh PP. Development and evaluation of fast-dissolving film of salbutamol sulphate. Drug Dev Ind Pharm. 2005;31(1):25-34. doi: 10.1081/ddc-43947, PMID 15704855.
Kumar AC, Prathap M, Venketeswararao P, Babu AS, Babu RN, Shanthi MS. Development of itraconazole immediate release pellets by using HPMC loaded in gelatin capsules. Int J Biol Pharm Res. 2012;3(7):904-5.
Kaur M, Malik B, Garg T, Rath G, Goyal AK. Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv. 2015;22(3):328-34. doi: 10.3109/10717544.2014.894594, PMID 24611942.
Semalty M, Semalty A, Kumar G. Formulation and characterization of mucoadhesive buccal films of glipizide. Indian J Pharm Sci. 2008;70(1):43-8. doi: 10.4103/0250-474X.40330, PMID 20390079.
Modgill V, Garg T, Goyal AK, Rath G. Permeability study of ciprofloxacin from ultra-thin nanofibrous film through various mucosal membranes. Artif Cells Nanomed Biotechnol. 2016;44(1):122-7. doi: 10.3109/21691401.2014.924007, PMID 24915047.
Weibel ER, Bacigalupe LD, Schmitt B, Hoppeler H. Allometric scaling of maximal metabolic rate in mammals: muscle aerobic capacity as determinant factor. Respir Physiol Neurobiol. 2004;140(2):115-32. doi: 10.1016/j.resp.2004.01.006, PMID 15134660.
West GB, Brown JH. The origin of allometric scaling laws in biology from genomes to ecosystems: towards a quantitative unifying theory of biological structure and organization. J Exp Biol. 2005;208(9):1575-92. doi: 10.1242/jeb.01589, PMID 15855389.
Abou el Ela AESF, Allam AA, Ibrahim EH. Pharmacokinetics and anti-hypertensive effect of metoprolol tartrate rectal delivery system. Drug Deliv. 2016;23(1):69-78. doi: 10.3109/10717544.2014.904021, PMID 24758140.
El Sayeh A, Abou el Ela F, Ibrahim EH, Allam AA. Bucco-adhesive tablets containing metoprolol tartarate: formulation, in vitro and in vivo characterization. J Drug Deliv Sci Technol. 2013;23(2):171-9. doi: 10.1016/S1773-2247(13)50026-8.
Sastry MSP, Satyanarayana NV, Diwan PV, Krishna DR. Formulation, phafmacokinetic and pharmacodynamic evaluation of fast releasing compressed propranolol. HCL suppositories. Drug Dev Ind Pharm. 1993;19(9):1089-96. doi: 10.3109/03639049309063003.
El-Feky YA, Mostafa DA, Al-Sawahli MM, El-Telbany RFA, Zakaria S, Fayez AM. Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits. J Pharm Pharmacol. 2020;72(5):682-98. doi: 10.1111/jphp.13239, PMID 32170884.
Liu C, Chang D, Zhang X, Sui H, Kong Y, Zhu R. Oral fast-dissolving films containing lutein nanocrystals for improved bioavailability: formulation development, in vitro and in vivo evaluation. AAPS PharmSciTech. 2017;18(8):2957-64. doi: 10.1208/s12249-017-0777-2, PMID 28462465.
Lai KL, Fang Y, Han H, Li Q, Zhang S, Li HY. Orally-dissolving film for sublingual and buccal delivery of ropinirole. Colloids Surf B Biointerfaces. 2018;163:9-18. doi: 10.1016/j.colsurfb.2017.12.015, PMID 29268211.
Londhe V, Shirsat R. Formulation and characterization of fast-dissolving sublingual film of iloperidone using box–behnken design for enhancement of oral bioavailability. AAPS PharmSciTech. 2018;19(3):1392-400. doi: 10.1208/s12249-018-0954-y, PMID 29396734.
Abd El Azim H, Nafee N, Ramadan A, Khalafallah N. Liposomal buccal mucoadhesive film for improved delivery and permeation of water-soluble vitamins. Int J Pharm. 2015;488(1-2):78-85. doi: 10.1016/j.ijpharm.2015.04.052, PMID 25899288.
Bermudez Oria A, Rodriguez Gutierrez G, Vioque B, Rubio Senent F, Fernandez Bolaños J. Physical and functional properties of pectin-fish gelatin films containing the olive phenols hydroxytyrosol and 3,4-dihydroxyphenylglycol. Carbohydr Polym. 2017;178:368-77. doi: 10.1016/j.carbpol.2017.09.042, PMID 29050607.
Junmahasathien T, Panraksa P, Protiarn P, Hormdee D, Noisombut R, Kantrong N. Preparation and evaluation of metronidazole-loaded pectin films for potentially targeting a microbial infection associated with periodontal disease. Polymers. 2018;10(9):1021. doi: 10.3390/polym10091021, PMID 30960947.
Raza SN, Kar AH, Wani TU, Khan NA. Formulation and evaluation of mouth dissolving films of losartan potassium using 32 factorial design. Int J Pharm Sci Res. 2019;10(3):1402-11.
Yir-Erong B, Bayor MT, Ayensu I, Gbedema SY, Boateng JS. Oral thin films as a remedy for noncompliance in pediatric and geriatric patients. Ther Deliv. 2019;10(7):443-64. doi: 10.4155/tde-2019-0032, PMID 31264527.
Hussain A, Latif S, Abbas N, Irfan M, Arshad MS, Bukhari NI. Hydroxypropyl cellulose-based orally disintegrating films of promethazine HCl for the treatment of motion sickness. Trop J Pharm Res. 2018;17(6):991-6. doi: 10.4314/tjpr.v17i6.2.
Adrover A, Varani G, Paolicelli P, Petralito S, Di Muzio L, Casadei MA. Experimental and modeling study of drug release from HPMC-based erodible oral thin films. Pharmaceutics. 2018;10(4):222. doi: 10.3390/pharmaceutics10040222, PMID 30423941.
Akyuz L, Duman F, Kaya M. Encapsulation of flurbiprofen by chitosan using a spray-drying method with in vitro drug releasing and molecular docking. Turk J Pharm Sci. 2017;14(1):34-9. doi: 10.4274/tjps.95867, PMID 32454592.
Shah J, Patel S, Bhairy S, Hirlekar R. Formulation optimization, characterization and in vitro anti-cancer activity of curcumin loaded nanostructured lipid carriers. Int J Curr Pharm Sci. 2022;14(1):31-43. doi: 10.22159/ijcpr.2022v14i1.44110.
Kaczmarek B. Improving sodium alginate films properties by phenolic acid addition. Materials (Basel). 2020;13(13):2895. doi: 10.3390/ma13132895, PMID 32605181.
Centkowska K, Ławrecka E, Sznitowska M. Technology of orodispersible polymer films with micronized loratadine-influence of different drug loadings on film properties. Pharmaceutics. 2020;12(3):250. doi: 10.3390/pharmaceutics12030250, PMID 32164345.
Ouda GI, Dahmash EZ, Alyami H, Iyire A. A novel technique to improve drug loading capacity of fast/extended release orally dissolving films with potential for paediatric and geriatric drug delivery. AAPS PharmSciTech. 2020;21(4):126. doi: 10.1208/s12249-020-01665-5, PMID 32382992.
Published
How to Cite
Issue
Section
Copyright (c) 2024 MEDISETTY GAYATRI DEVI, SANTHOSH KUMAR R.
This work is licensed under a Creative Commons Attribution 4.0 International License.
